Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipoylated tricarboxylic acid (TCA) cycle enzymes are a group of mitochondrial multi-enzyme complexes, including pyruvate dehydrogenase (PDH) and alpha-ketoglutarate dehydrogenase (KGDH), that require the covalent attachment of lipoic acid for catalytic function (UniProt, 2024). These enzymes play a central role in cellular respiration by facilitating the conversion of metabolic intermediates into energy (Tsvetkov et al., 2022). The lipoylation process is regulated by the protein ferredoxin 1 (FDX1), which acts as a master regulator of this post-translational modification (Science, 2022). Recent research has identified these lipoylated enzymes as the key mediators of cuproptosis, a copper-dependent form of regulated cell death (Nature Chemical Biology, 2022). In this process, copper ionophores like elesclomol transport copper into the mitochondria, where the metal binds directly to the lipoylated components (PubChem, 2024). This binding leads to protein aggregation, loss of iron-sulfur cluster proteins, and severe proteotoxic stress, ultimately resulting in cell death (Frontiers in Oncology, 2022). This pathway is a promising therapeutic target in oncology, as many cancer cells exhibit increased mitochondrial metabolism and heightened sensitivity to copper-induced proteotoxicity compared to normal cells (Tsvetkov et al., 2022).
Induction of cuproptosis via copper-dependent aggregation of lipoylated enzymes, leading to proteotoxic stress and inhibition of the tricarboxylic acid cycle.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipoylated tricarboxylic acid cycle enzymes.